APOA1 and fatty liver disease: After adjustment for age and gender (Model 1) and for age, gender, glucose, triglycerides, apoA1, apoB100, and AST (Model 2), the associations between FABP4 and liver steatosis were significant in all the studied groups, including obese patients.